Skip to main content

The Framingham risk score is associated with incident frailty, or is it?



Cardiovascular disease (CVD) risk factors are individually associated with frailty. This study examined whether Framingham CVD risk score (FRS) as an aggregate measure of CVD risk is associated with incident frailty among Chinese older adults.


This study used data from the China Health and Retirement Longitudinal Study. A sample of 3,618 participants aged 60 to 95 years and without CVD at baseline were followed for four years. FRS was calculated at baseline. Frailty status was defined as not-frail (0–2 criteria) or frail (3–5 criteria) based on the physical frailty phenotype consisting of five binary criteria (weakness, slowness, exhaustion, low activity level, and weight loss). After excluding subjects who were frail (n = 248) at baseline, discrete-time Cox regression was used to evaluate the relationship between FRS and incident frailty.


During a median follow-up of 4.0 years, 323 (8 %) participants developed CVD and 318 (11 %) subjects had frailty onset. Higher FRS was associated with greater risk of incident frailty (HR: 1.03, 95 % CI: 1.00 to 1.06) after adjusting for education, marital status, obesity, comorbidity burden, and cognitive function. This association however was no longer significant (HR: 1.00, 95 % CI: 0.97 to 1.03) after additionally adjusting for age. These findings remained essentially unchanged after excluding subjects with depression (n = 590) at baseline or incident CVD (n = 323) during the 4-year follow-up.


The FRS was not independently associated with incident frailty after adjusting for chronological age. More research is needed to assess the clinical utility of the FRS in predicting adverse health outcomes other than CVD in older adults.

Peer Review reports


By 2050, it is expected that one in four Chinese citizens will be 65 years of age or older [1]. Population aging is believed to be responsible for the growing prevalence of cardiovascular disease (CVD) and frailty in China. Frailty and CVD are two common and often coexisting conditions in the elderly that share many risk factors (hypertension, smoking, obesity, diabetes, and dyslipidemia), and exert a substantial influence on clinical outcomes [2, 3] (e.g., disability, sarcopenia and dementia). The generalized Framingham risk score (FRS) [generalized FRS; 2008] [4] is a standard tool for assessing the 10-year risk of CVD events (i.e., coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure). In 2015, an updated FRS [2015] calculator ( was published. It has been shown that higher FRS is associated with multiple adverse health outcomes, e.g., incident chronic kidney disease (CKD) [5], sarcopenia [6], and cognitive decline [7]. Frailty is a geriatric syndrome characterized by reduced physiological reserve and increased vulnerability for poor recovery of homeostasis after a stressor event [8]. Frailty poses a high risk of developing negative health outcomes including incident disability [9], falls [10], fracture [11], and mortality [12].

Several studies have shown cross-sectional associations between frailty and CVD risk factors [13,14,15,16]. It is therefore expected that the FRS may be useful in identifying individuals at increased risk of developing frailty. In addition, researches in the Whitehall II prospective cohort study and the English Longitudinal Study reported that higher sex-specific FRS was associated with increased risk of incident frailty [17, 18] as defined by the physical frailty phenotype [19]. Given that age is a part of the FRS algorithm and frailty is age-related, the degree to which the association between FRS and frailty is driven by age in older adults is unknown. To address this question, we examined the predictive value of FRS versus age for incident frailty among community-dwelling Chinese older adults enrolled in the China Health and retirement Longitudinal Study (CHARLS).


Study population

The study sample consists of Chinese residents aged ≥ 45 years who were recruited from 28 provinces in China. A total of 17,708 residents were interviewed at wave 1 (baseline) between 2011 and 2012, and were followed every 2 years thereafter. All participants gave informed consent; ethical approval for all the CHARLS waves was granted from the Institutional Review Board (IRB) at Peking University. The IRB approval number for the main household survey, including anthropometrics, is IRB00001052-11015; the IRB approval number for biomarker collection, was IRB00001052-11014. Further details about the recruitment strategy, design, and sampling approaches of the CHARLS have been supplied elsewhere [20].

We utilized the Framingham Risk factors measured at baseline to predict the risk of developing frailty at wave 2 (2013–2014) and wave 3 (2015–2016). We included participants who (i) were 60 years of age or old, (ii) had complete data on FRS and frailty, and (iii) no history of CVD at baseline (see flowchart of sample selection in Fig. 1).

Fig. 1

Flow chart of Participants through the study

FRS at baseline

Data on the FRS components (age, HDL, total cholesterol, systolic blood pressure, treatment for hypertension, smoking and diabetes) was taken from wave 1. Blood samples were collected from vein in fasting state (fasting more than 12 h) by professional staff from the Chinese Center for Disease Control and Prevention (China CDC). Fasting glucose and lipid profiles (e.g., total cholesterol, high-density lipids cholesterol, low-density lipids cholesterol) were measured by the enzymatic colorimetric test [20, 21]. Systolic blood pressure (SBP) was measured three times using an Omron HEM-7200 blood pressure monitor with the participant seated [20]. Antihypertensive therapy was defined by self-report of currently taking Chinese traditional or western medication to treat or control hypertension. Current smoking (yes/no) was defined by self-report. Prevalent diabetes mellitus was defined based on self-report of doctor-diagnosed diabetes, use of diabetes medication or insulin injections, a hemoglobin A1C level ≥ 6.5 %, or a baseline fasting plasma glucose level > 126 mg/dl. Total FRS is obtained by summing up the points from all risk components. A higher FRS indicates a greater risk for future CVD events [4].


Frailty was measured using a modified version of the physical frailty phenotype (PFP) [19, 22]. This measure comprised of five binary criteria: weakness, slowness, exhaustion, low activity level and weight loss. Those with 3 or more criteria were deemed frail.


Grip strength by sex and quartiles of body mass index (BMI; kg/\({\text{m}}^{2}\)): Weakness was defined, using maximum handgrip strength of either hand (two trials for each; measured in a standing position), as ≤ 20th percentile of the weighted sample distribution, adjusting for sex and body mass index (BMI). Subjects who were tried but unable to perform, could not participate due to health reasons or felt unsafe were considered meeting the weakness criterion.


Gait speed over a 2.5-meter course by sex and median standing height (cm): Slowness was defined, using the average of two-timed walk tests over a 2.5-meter course, as being ≤ 20th percentile of the weighted sample distribution, adjusting for sex and height via a residual-based approach described previously. Subjects who were unable to walk or felt unsafe were considered meeting the slowness criterion.


Exhaustion is characterized by two questions from the modified 10-item Center for Epidemiological Studies-Depression scale. Two questions were, “I could not get going” and “I felt everything I did was an effort”. If Participants answered “a moderate amount of time (3–4 days)” or “most of the time (5–7 days)” to either of these items, they met the criteria for exhaustion.

Low activity level

Physical activity was measured using the International Physical Activity Questionnaire Short Form (IPAQ-SF) [23]. Participants who self-reported that they did not walk ≥ 10 min continuously during a usual week were considered sedentary.

Weight loss

Weight loss was defined as self-reported weight loss of 5 or more kilograms in the previous year (at wave 1) or loss of ≥ 10 % since last wave (at wave 2 and wave 3) or BMI ≤ 18.5 kg/m2.

Ascertainment of incident CVD events

Incident CVDs were assessed over the follow-up period (wave 2 to wave 3), using the following standardized questions: “Have you been told by a doctor that you have been diagnosed with a heart attack, coronary heart disease, angina, congestive heart failure, or other heart problems?” or “Have you been told by a doctor that you have been diagnosed with a stroke?” Participants who reported heart disease or stroke during the follow-up period were defined as having incident CVD [24, 25].

Covariates at baseline

Demographics included age, sex, education, marital status, and current residence location. Body mass index (BMI) was calculated as weight (kilograms) divided by height (meters) squared, then classified into non-obese (BMI < 28 kg/m2) and obese (BMI ≥ 28.0 kg/m2) [26]. Cognitive function was evaluated by the Telephone Interview of Cognitive Status (TICS) [27], with a score ranging 0–21 and higher score representing better cognitive function. Depression symptoms were assessed using the modified 10-item CES-D scale [20] after excluding two items used to define exhaustion (a frailty criterion), with a total score of 12 or higher indicating depression [28]. Comorbid disease burden was measured by the total number of chronic conditions including cancer (excluding skin cancers), chronic lung diseases, liver disease, kidney disease, stomach or other digestive disease, arthritis/rheumatism, and asthma.

Statistical analysis

We used ANOVA and chi-square tests to compare the distributions of continuous and categorical variables respectively by baseline frailty status (not-frail vs. frail). After excluding prevalent frailty at baseline, we conducted the discrete-time Cox regression (DTSA) to examine the association between the components of FRS measured at baseline and frailty incidence during the follow-up. When examining the association between FRS and incident frailty, we fit three nested models with increasing number of confounders: sex only (Model 1); sex, education, marital status, obesity, comorbidity burden, and cognitive function (Model 2); and those of Model 2 plus age (Model 3).

We conducted three sensitivity analyses. First, in order to examine whether the association between FRS and incident frailty was driven by incident CVD, we repeated the analysis after excluding incident CVD cases over the follow-up period. In addition, to eliminate the influence of depressive symptoms on frailty measurement, we refit the model by restricting the analysis to those without depression [28]. Third, to explore the effect of competing mortality, we modeled mortality and/or incident frailty as a composite outcome. Finally, in order to determine whether different versions of the FRS would impact the association between FRS and incident frailty, baseline FRS were calculated using both the generalized FRS [2008] and the updated FRS [2015] algorithm.

P-value < 0.05 was considered statistically significant, and all analyses were performed using Stata 15.1 (Stata Corp, College Station, TX).


Sample description

Table 1 compares the baseline characteristics of 3,618 participants by baseline frailty status. There were 3,313 (91.6 %) classified as not-frail and 305 (8.4 %) as frail. Compared with the not-frail, frail participants were more likely to be older, have worse cognitive function, more depressive symptoms, and greater comorbidity burden. The FRS components except HDL cholesterol did not significantly vary by frailty status at baseline.

Table 1 Characteristics of study sample by baseline frailty status (n= 3,618a)

Association between FRS and incident frailty

The association between each component of the generalized FRS [2008] at baseline and incident frailty during the follow-up is presented in Table 2. Older age, lower level of total cholesterol, and smoking were associated with greater risk of incident frailty in both sex-adjusted and fully-adjusted models. On the other hand, a one SD increase in total cholesterol predicted a 24.0 % (Hazard Ratio [HR] 0.76, 95 % CI 0.66–0.89) and 17.0 % (HR 0.83, 95 % CI 0.71–0.96) lower risk of incident frailty in sex-adjusted and fully-adjusted models, respectively. These associations were not statistically different by sex except for antihypertensive treatment (results not shown), where the association was weaker among females compared to males (P = 0.033).

Table 2 Association between each cardiovascular disease risk factor at baseline (wave 1) and incident frailty during the follow-up (wave2-wave3). (n=2,901)

The association between the FRS at baseline and incident frailty is shown in Table 3. There was a significant association between increasing FRS at baseline and increasing risk of incident frailty after adjusting for sex (HR 1.03, 95 % CI 1.01–1.06; Model 1). Further adjustment of education, marital status, obesity, comorbidity burden, cognitive function had little impact (HR 1.03, 95 % CI 1.00-1.06). The association however became insignificant after additionally adjusting for age (HR 1.00, 95 % CI 0.97–1.03; Model 3). The results showed similar trends when the updated FRS [2015] was used instead of the generalized FRS [2008].

Table 3 Associate between the Framingham Risk Score (FRS) at baseline (wave 1) and incident frailty during the follow-up (wave2-wave3)

Sensitivity analyses

The results barely changed after excluding incident CVD cases (n = 323, Table 3). The results were also similar after excluding subjects with depression at baseline (n = 590). After adjusting for age, the associations again became non-significant. In Table 4, we present the association between FRS and the composite outcome of mortality and incident frailty. The findings remained the same.

Table 4 Associate between FRS at baseline (wave 1) and combined mortality and incident frailty during the follow-up (wave2-wave3)


Despite previous research showing an association between high risk of CVD and pre-frailty [29] or frailty [3], there are still knowledge gaps regarding the association between the FRS and frailty in older adults. The present study aimed to examine whether the FRS was useful in predicting future risk of frailty after accounting for chronological age. In this study, we found that the FRS was not independently associated with the development of frailty after adjusting for age. The FRS therefore failed to offer added value in predicting incident frailty beyond chronological age.

In this large population sample of Chinese older adults without a history of CVD at baseline, CVD risk factors including total cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes did not significantly differ by frailty status at baseline. In this study, high total cholesterol level was associated with lower risk of incident frailty (a.k.a. cholesterol paradox), which may be caused by survival bias [30]. Without adjusting for age, we found that higher FRS at baseline was associated with a higher risk of incident frailty during follow-up. Adjustment for potential confounding factors had little effect on the association, and the results remained essentially unchanged by excluding those who developed CVD during follow-up or had depression at baseline, which is consistent with the sex-specific results reported by others [17, 18]. However, the FRS and incident frailty relationship was lost when age was added to the multivariable model, suggesting that the age component of the FRS may be the primary driver of the relationship between FRS and incident frailty. This result is in agreement with one meta-analysis [31], which suggested that the FRS was no more strongly associated with future dementia than age. A cross-sectional analysis using data from the International Mobility in Aging Study found that frail older adults, compared to the non-frail, had higher FRS, and the association was independent of life course adversities (e.g., childhood social economic adversity) [32]. However, this cross-sectional study did not exclude prevalent CVD cases, which is a prerequisite for using the FRS to predict future health related outcome [4]. The non-significant association between diabetes and incident frailty in our cohort was a bit surprising. We found a strong positive association between CVD and diabetes at baseline. It is therefore possible that the reported association in the literature [33] between diabetes and frailty was partially due to confounding by CVD. In our study, diabetes was positively associated with incident frailty; the association however was not statistically significant. Therefore, the non-significance was likely due to the exclusion of prevalence cases of CVD at baseline.

To our knowledge, this is the first study to examine the longitudinal association between the FRS and incident frailty among older adults in China. Other strengths of our study include large sample size and the use of a well-validated frailty assessment. This study has several limitations. First, because the reported associations between FRS and incident frailty were limited to 4 years instead of 10 years, it is possible that a longer-term follow-up may reveal a positive relationship. Second, information on prevalent and incident CVD was based solely on self-report, this might have underestimated the actual CVD incidence, especially in rural areas [34, 35]. Third, not all participants at baseline provided a blood sample (a response rate of 67 %). Those who did not provide a blood sample tended to be man and urban residents [36], therefore introducing potential sample selection bias. Fourth, weight loss at baseline was defined as weight loss of 5 or more kilograms in the past year, instead of a loss of ≥ 10 % since last wave that was used at wave 2 and wave 3. However, the same criteria were used in previous studies [19, 22]. Fifth, compared to the analytic sample, those who were excluded due to missing data on FRS and frailty status were older, more likely to be non-smoker, and have less comorbidity burden and no diabetes (Table S1), which could introduce bias to the analysis. Finally, our findings might have been impacted by competing mortality, i.e., those who had higher Framingham score were more likely to die before frailty onset or whose frailty onset was not captured before death or dropout due to the discrete nature of the follow-up (i.e., every two years). But when we modeled incident frailty and mortality as a composite outcome, the association between FRS and combine outcome remained non-significant after adjusting for age.


In summary, although CVD risk factors have been linked to frailty, this study found that the FRS was not associated with incident frailty independent of chronological age in Chinese older adults. It therefore offers no added value in predicting incident frailty. More studies are needed to understand the impact of CVD risk factors in the pathogenesis of frailty. In addition, further studies are necessary to clarify the predictive performance of FRS relative to chronological age in adverse health outcomes such as CKD [5], sarcopenia [6] and cognitive decline [7].

Availability of data and materials

The raw data is available on website (


  1. 1.

    United Nations, Population Division. World Population Prospects 2019. Accessed 2 July 2019.

  2. 2.

    Amarasekera AT, Chang D, Schwarz P, Tan TC. Does vascular endothelial dysfunction play a role in physical frailty and sarcopenia? A systematic review. Age Ageing. 2021;50(3):725–32.

  3. 3.

    Stewart R. Cardiovascular disease and frailty: what are the mechanistic links? Clin Chemist. 2019;65(1):80–6.

    CAS  Article  Google Scholar 

  4. 4.

    D’Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.

    Article  Google Scholar 

  5. 5.

    Lee C, Yun HR, Joo YS, Lee S, Kim J, Nam KH, Jhee JH, Park JT, Yoo TH, Kang SW, et al. Framingham risk score and risk of incident chronic kidney disease: a community-based prospective cohort study. Kidney Res Clin Pract. 2019;38(1):49–59.

    Article  Google Scholar 

  6. 6.

    Byeon CH, Kang KY, Kang SH, Bae EJ. Sarcopenia is associated with Framingham risk score in the Korean population: Korean National Health and Nutrition Examination Survey (KNHANES) 2010–2011. J Geriatr Cardiol. 2015;12(4):366–72.

    PubMed  PubMed Central  Google Scholar 

  7. 7.

    Viticchi G, Falsetti L, Buratti L, Boria C, Luzzi S, Bartolini M, Provinciali L, Silvestrini M. Framingham risk score can predict cognitive decline progression in Alzheimer’s disease. Neurobiol Aging. 2015;36(11):2940–5.

    Article  Google Scholar 

  8. 8.

    Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet(London, England). 2013;381(9868):752–62.

  9. 9.

    Zhang Q, Zhao X, Liu H, Ding H. Frailty as a predictor of future falls and disability: a four-year follow-up study of Chinese older adults. BMC Geriatrics. 2020;20(1):388.

    Article  Google Scholar 

  10. 10.

    Kojima G. Frailty as a predictor of future falls among community-dwelling older people: a systematic review and meta-analysis. J Am Med Direct Assoc. 2015;16(12):1027–33.

    Article  Google Scholar 

  11. 11.

    Tom SE, Adachi JD, Anderson FA Jr., Boonen S, Chapurlat RD, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, et al. Frailty and fracture, disability, and falls: a multiple country study from the global longitudinal study of osteoporosis in women. J Am Geriatr Soc. 2013;61(3):327–34.

    Article  Google Scholar 

  12. 12.

    Kulmala J, Nykänen I, Hartikainen S. Frailty as a predictor of all-cause mortality in older men and women. Geriatr Gerontol Int. 2014;14(4):899–905.

    Article  Google Scholar 

  13. 13.

    Boreskie KF, Rose AV, Hay JL, Kehler DS, Costa EC, Moffatt TL, Arora RC, Duhamel TA. Frailty status and cardiovascular disease risk profile in middle-aged and older females. Exp Gerontol. 2020;140:111061.

    Article  Google Scholar 

  14. 14.

    Ricci NA, Pessoa GS, Ferriolli E, Dias RC, Perracini MR. Frailty and cardiovascular risk in community-dwelling elderly: a population-based study. Clin Interv Aging. 2014;9:1677–85.

    Article  Google Scholar 

  15. 15.

    Ramsay SE, Arianayagam DS, Whincup PH, Lennon LT, Cryer J, Papacosta AO, Iliffe S, Wannamethee SG. Cardiovascular risk profile and frailty in a population-based study of older British men. Heart. 2015;101(8):616–22.

    CAS  Article  Google Scholar 

  16. 16.

    Newman AB, Gottdiener JS, McBurnie MA, Hirsch CH, Kop WJ, Tracy R, Walston JD, Fried LP. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001;56(3):M158-166.

    CAS  Article  Google Scholar 

  17. 17.

    Bouillon K, Batty GD, Hamer M, Sabia S, Shipley MJ, Britton A, Singh-Manoux A, Kivimäki M. Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study. Heart. 2013;99(10):737–42.

    CAS  Article  Google Scholar 

  18. 18.

    Gale CR, Cooper C, Sayer AA. Framingham cardiovascular disease risk scores and incident frailty: the English longitudinal study of ageing. Age (Dordrecht, Netherlands). 2014;36(4):9692.

    Article  Google Scholar 

  19. 19.

    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-156.

    Article  Google Scholar 

  20. 20.

    Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.

    Article  Google Scholar 

  21. 21.

    Chen X, Crimmins E, Hu PP, Kim JK, Meng Q, Strauss J, Wang Y, Zeng J, Zhang Y, Zhao Y. Venous blood-based biomarkers in the China health and retirement longitudinal study: rationale, design, and results from the 2015 wave. Am J Epidemiol. 2019;188(11):1871–7.

    Article  Google Scholar 

  22. 22.

    Wu C, Smit E, Xue QL, Odden MC. Prevalence and Correlates of Frailty Among Community-Dwelling Chinese Older Adults: The China Health and Retirement Longitudinal Study. J Gerontol A Biol Sci Med Sci. 2017;73(1):102–8.

    Article  Google Scholar 

  23. 23.

    IPAQ committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). 2005.

  24. 24.

    Zheng F, Yan L, Zhong B, Yang Z, Xie W. Progression of cognitive decline before and after incident stroke. Neurology. 2019;93(1):e20–8.

  25. 25.

    Xie W, Zheng F, Yan L, Zhong B. Cognitive decline before and after incident coronary events. J Am College Cardiol. 2019;73(24):3041–50.

    Article  Google Scholar 

  26. 26.

    Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17:1–36.

    PubMed  Google Scholar 

  27. 27.

    Brandt J, Spencer M, Folstein MJC. Neurology B: The Telephone Interview for Cognitive Status. 1988;1(2).

  28. 28.

    Cheng ST, Chan AC. The center for epidemiologic studies depression scale in older Chinese: thresholds for long and short forms. Int J Geriatr Psychiatry. 2005;20(5):465–70.

    Article  Google Scholar 

  29. 29.

    Sergi G, Veronese N, Fontana L, De Rui M, Bolzetta F, Zambon S, Corti MC, Baggio G, Toffanello ED, Crepaldi G, et al. Pre-frailty and risk of cardiovascular disease in elderly men and women: the Pro.V.A. study. J Am College Cardiol. 2015;65(10):976–83.

    Article  Google Scholar 

  30. 30.

    Orkaby AR. The highs and lows of cholesterol: a paradox of healthy aging? J Am Geriatr Soc. 2020;68(2):236–7.

    Article  Google Scholar 

  31. 31.

    Russ TC, Hamer M, Stamatakis E, Starr JM, Batty GD, Kivimäki M. Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women. Atherosclerosis. 2013;228(1):256–8.

    CAS  Article  Google Scholar 

  32. 32.

    Fernandes J, Gomes CDS, Guerra RO, Pirkle CM, Vafaei A, Curcio CL, Dornelas de Andrade A. Frailty syndrome and risk of cardiovascular disease: analysis from the international mobility in aging study. Arch Gerontol Geriatr. 2021;92:104279.

    Article  Google Scholar 

  33. 33.

    Chhetri JK, Zheng Z, Xu X, Ma C, Chan P. The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatrics. 2017;17(1):47.

    Article  Google Scholar 

  34. 34.

    Ning M, Zhang Q, Yang M. Comparison of self-reported and biomedical data on hypertension and diabetes: findings from the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2016;6(1):e009836.

    Article  Google Scholar 

  35. 35.

    Wang Q, Shen JJ, Frakes K. Limited contribution of health behaviours to expanding income-related chronic disease disparities based on a nationwide cross-sectional study in China. Sci Rep. 2018;8(1):12485.

    Article  Google Scholar 

  36. 36.

    Zhao Y, Strauss J, Yang G, et al. China Health and Retirement Longitudinal Study: 2011–2012 National Baseline Blood data Users’ Guide. Beijing: National School of Development, Peking University; 2014.

    Google Scholar 

Download references


We thanked the China Center for Economic Research, the National School of Development of Peking University for providing the data.


This work was supported by Chengdu Science and Technology Bureau Major Science and Technology Application Demonstration Project (2019YF0900083SN). The funder played no role in study design, data collection, and analysis, the decision to publish, or preparation of the manuscript.

Author information




Study concept and design: HS and MLG. HS and QLX developed study concept and designed the study. HS and MLG performed data extraction and statistical analyses. HS, MLG, BRD and QLX participated in drafting the article. MLG, BRD and QLX made critical revision of the manuscript. All authors approved the final version of the article, and ensured the accuracy and integrity of this work.

Corresponding authors

Correspondence to Mei-Ling Ge or Qian-Li Xue.

Ethics declarations

Ethics approval and consent to participate

This study was conducted in accordance with the declaration of Helsinki. Ethical approval for all the CHARLS waves was granted from the Institutional Review Board (IRB) at Peking University. The IRB approval number for the main household survey, including anthropometrics, is IRB00001052-11015; the IRB approval number for biomarker collection, is IRB00001052-11014. During the fieldwork, each respondent who agreed to participate in the survey was asked to sign two copies of the informed consent. Four separate consents were obtained: one for the main fieldwork, one for the non-blood biomarkers and one for the taking of the blood samples, and another for storage of blood for future analyses.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Comparison of baseline characteristics of study subjects excluded due to missing data on FRS and frailty status and those sample included in the final analysis (n= 6,249)

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shi, H., Ge, ML., Dong, B. et al. The Framingham risk score is associated with incident frailty, or is it?. BMC Geriatr 21, 448 (2021).

Download citation


  • Framingham risk score
  • Cardiovascular disease
  • Frailty
  • Cohort study